发明名称 |
Phosphate-containing nanoparticle delivery vehicle |
摘要 |
A phosphate-containing nanoparticle delivery vehicle includes nanoparticle, an active ingredient, and a phosphodiester moiety connecting the nanoparticle and the active ingredient and forms a prodrug. The nanoparticle delivery vehicle achieves the function of increasing hydrophilicity of the active ingredient and specificity against tumor cells. Advantages of the nanoparticle material include biocompatibility, magnetism and/or controllable drug release. |
申请公布号 |
US8846644(B2) |
申请公布日期 |
2014.09.30 |
申请号 |
US201213548856 |
申请日期 |
2012.07.13 |
申请人 |
National Cheng-Kung University |
发明人 |
Hwu Jih Ru;Lin Yu-Sern;Yeh Chen-Sheng;Shieh Dar-Bin;Su Wu-Chou |
分类号 |
C07D493/00;A61K38/00;A61K9/16;C07F9/6558;A61K47/48;A61K31/665;C07F9/655 |
主分类号 |
C07D493/00 |
代理机构 |
Muncy, Geissler, Olds & Lower, P.C. |
代理人 |
Muncy, Geissler, Olds & Lower, P.C. |
主权项 |
1. A phosphate-containing nanoparticle delivery vehicle of the formula:wherein NP is a nanoparticle, and the nanoparticle comprises a core domain and contains more than one metallic element, semiconductor element or an organic condensed matter or the nanoparticle is made of a member selected from the group consisting of silver, cobalt, nickel, titanium dioxide, zinc oxide, tin dioxide, copper, aluminum, cadmium selenide, silicon dioxide and diamond, wherein the metallic element is a member selected from the group consisting of silver, aluminum, platinum, palladium, copper, cobalt, iron, nickel, manganese, gadolinium, molybdenum;
R1 is paclitaxel; R2 is OH; each of X, Y is O; and Z is O. |
地址 |
Tainan TW |